Clinical Trial Delay Covid-19

Phase 2 Trial Of Topical FOL-005 Has Resumed- Update 6/9/20 After a nearly 3 month intermission due to coronavirus restraints, Follicum is now able to continue recruitment for its phase 2 trial of a topical FOL-005 formulation. In addition to restarting the trial, Follicum has enlisted a third study center, CentroDerm of Wuppertal, Germany, to…